chr4-186232278-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000892.5(KLKB1):c.210C>A(p.Asp70Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000892.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLKB1 | NM_000892.5 | c.210C>A | p.Asp70Glu | missense_variant | 3/15 | ENST00000264690.11 | NP_000883.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLKB1 | ENST00000264690.11 | c.210C>A | p.Asp70Glu | missense_variant | 3/15 | 1 | NM_000892.5 | ENSP00000264690 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251482Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135914
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461676Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 727156
GnomAD4 genome AF: 0.000453 AC: 69AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | The c.210C>A (p.D70E) alteration is located in exon 3 (coding exon 2) of the KLKB1 gene. This alteration results from a C to A substitution at nucleotide position 210, causing the aspartic acid (D) at amino acid position 70 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at